FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079593 [Registered on: 27/01/2025] Trial Registered Prospectively
Last Modified On: 19/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of dose response to two different doses of intravenous anaesthetic drug lidocaine for postoperative pain relief 
Scientific Title of Study   Comparison of dose response to two different doses of intravenous lidocaine for postoperative analgesia in patients undergoing elective laparoscopic gynaecological oncology surgery under general anaesthesia : A Prospective randomised controlled study  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rakshitha K S 
Designation  Post graduate resident 
Affiliation  Kidwai memorial institute of oncology 
Address  Room 105, Department of Anaesthesiology and pain relief, Ground floor, OT complex block, Kidwai memorial institute of oncology, Dr MH Marigowda road, Bangalore.

Bangalore
KARNATAKA
560029
India 
Phone  9916149044  
Fax    
Email  rakshithagowdaks5@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sumitha C S 
Designation  Associate Professor 
Affiliation  Kidwai memorial institute of oncology 
Address  Room 105, Department of Anaesthesiology and pain relief, Ground floor, OT Complex block, Kidwai memorial institute of oncology, Dr MH Marigowda road, Bangalore.

Bangalore
KARNATAKA
560029
India 
Phone  9980524241  
Fax    
Email  cssumitha@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sumitha C S 
Designation  Associate Professor 
Affiliation  Kidwai memorial institute of oncology 
Address  Room 105, Department of Anaesthesiology and pain relief, Ground floor, OT Complex block, Kidwai memorial institute of oncology, Dr MH Marigowda road, Bangalore.

Bangalore
KARNATAKA
560029
India 
Phone  9980524241  
Fax    
Email  cssumitha@yahoo.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology and pain relief, Room 105, Ground floor, OT Complex block, Kidwai memorial institute of oncology, Dr MH Marigowda road, Bangalore, Karnataka, India. 560029 
 
Primary Sponsor  
Name  Dr Rakshitha K S 
Address  Room 105, Department of Anaesthesiology and pain relief, Ground floor, OT Complex block, Kidwai memorial institute of oncology, Dr MH Marigowda road, Bangalore. 560029 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rakshitha K S  Kidwai memorial institute of oncology  Department of Anaesthesiology and pain relief, Room 105, Ground floor, OT Complex block, Kidwai memorial institute of oncology, Dr MH Marigowda road, Bangalore.
Bangalore
KARNATAKA 
9916149044

rakshithagowdaks5@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Medical ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C574||Malignant neoplasm of uterine adnexa, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  intravenous lidocaine infusion  Before induction of anaesthesia intravenous lidocaine bolus of 1.5mg/kg slowly over 10 mins followed by 1.5mg/kg/hr infusion after induction of anaesthesia for 3 hours. Postoperative VAS score monitoring is done.  
Intervention  intravenous lidocaine infusion   Before induction of anaesthesia intravenous lidocaine bolus of 1.5mg/kg slowly over 10 mins followed by 2mg/kg/hr infusion after induction of anaesthesia for 3 hours. Postoperative VAS score monitoring is done and compared with the other group. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  1 Patients aged between 18 and 65 years
2 Patients belonging to ASA physical status 1 and 2
3 Patients consenting for study 
 
ExclusionCriteria 
Details  1 Patients with cardiac, respiratory, hepatic or renal diseases.
2 Patients with neurological disorder.
3 Patients with history of alcohol or any drug addiction.
4 Pregnant or breastfeeding females.
5 Known allergic to local anaesthetics. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Assessing Visual Analogue Score(VAS) in postoperative period  24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
1. Intraoperative hemodynamic stability
2. Intraoperative requirement of opioids.
3. Assessing time to first analgesic dose and total consumption of rescue analgesic in 24 hours.
4. Side effects of intravenous lidocaine.
 
24 hours 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a randomised controlled study comparing the dose response of two different doses of intravenous lidocaine for post operative analgesia. In patients undergoing laparoscopic gynaecological oncologic surgery , patients are allocated into two groups. Patients in group A will receive an intravenous lidocaine bolus of 1.5 mg/kg slowly over 10 mins prior to induction followed by a continuous infusion at the rate of 1.5mg/kg/hour via infusion pump. Patients in group B will receive an intravenous lidocaine bolus of 1.5 mg/kg slowly over 10 mins prior to induction followed by a continuous infusion at the rate of 2 mg/kg/hour via infusion pump. Maintenance of anaesthesia is same in both groups. Primary objective of this study is to assess visual analogue pain score in post operative period and secondary objectives are intraoperative hemodynamic stability, intraoperative opioid requirement , assessing time to first analgesic dose, total consumption of rescue analgesic in 24 hours and side effects of intravenous lidocaine. 
Close